{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:54:42Z","timestamp":1786996482978,"version":"build-2736575974"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.sapharm.2023.11.002","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T04:43:02Z","timestamp":1700800982000},"page":"182-189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Development and validation of a brief screening tool for over-the-counter codeine dependence"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1254-9610","authenticated-orcid":false,"given":"Jacqui","family":"McCoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5341-1055","authenticated-orcid":false,"given":"Suzanne","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6673-833X","authenticated-orcid":false,"given":"Raimondo","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2023.11.002_bib1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/7854_2015_422","article-title":"Over-the-counter codeine - from therapeutic use to dependence, and the grey areas in between","volume":"34","author":"Nielsen","year":"2017","journal-title":"Curr Top Behav Neurosci"},{"issue":"11","key":"10.1016\/j.sapharm.2023.11.002_bib2","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.puhe.2015.06.014","article-title":"The availability of over-the-counter codeine medicines across the European Union","volume":"129","author":"Foley","year":"2015","journal-title":"Publ Health"},{"issue":"6","key":"10.1016\/j.sapharm.2023.11.002_bib4","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00228-021-03158-1","article-title":"The association between the availability of over the counter codeine and the prevalence of non-medical use","volume":"78","author":"Hockenhull","year":"2022","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.sapharm.2023.11.002_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.2042-7174.2012.00247.x","article-title":"Opportunities and challenges: over-the-counter codeine supply from the codeine consumer\u2019s perspective","volume":"21","author":"Nielsen","year":"2013","journal-title":"Int J Pharm Pract"},{"issue":"2","key":"10.1016\/j.sapharm.2023.11.002_bib6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1526-4637.2005.05031.x","article-title":"Universal precautions in pain medicine: a rational approach to the treatment of chronic pain","volume":"6","author":"Gourlay","year":"2005","journal-title":"Pain Med"},{"issue":"5","key":"10.1016\/j.sapharm.2023.11.002_bib7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/ADM.0000000000000525","article-title":"Screening, brief intervention, and referral to treatment in a retail pharmacy setting: the pharmacist's role in identifying and addressing risk of substance use disorder","volume":"13","author":"Shonesy","year":"2019","journal-title":"J Addiction Med"},{"issue":"8","key":"10.1016\/j.sapharm.2023.11.002_bib8","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.sapharm.2023.05.003","article-title":"A scoping literature review of pharmacy-based opioid misuse screening and brief interventions","volume":"19","author":"Rao","year":"2023","journal-title":"Res Soc Adm Pharm"},{"issue":"5","key":"10.1016\/j.sapharm.2023.11.002_bib9","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.amepre.2016.04.013","article-title":"Alcohol electronic screening and brief intervention: a community guide systematic review","volume":"51","author":"Tansil","year":"2016","journal-title":"Am J Prev Med"},{"issue":"2","key":"10.1016\/j.sapharm.2023.11.002_bib10","article-title":"Effectiveness of brief alcohol interventions in primary care populations","author":"Kaner","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.sapharm.2023.11.002_bib11","article-title":"A scoping review of codeine use, misuse and dependence, final report","author":"Van Hout","year":"2014"},{"key":"10.1016\/j.sapharm.2023.11.002_bib12","series-title":"Over the Counter Codeine Dependence","author":"Nielsen","year":"2010"},{"issue":"5","key":"10.1016\/j.sapharm.2023.11.002_bib13","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1360-0443.1995.9056072.x","article-title":"The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users","volume":"90","author":"Gossop","year":"1995","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.sapharm.2023.11.002_bib14","first-page":"270","article-title":"Estimation of cutoff for the Severity of Dependence Scale (SDS) for opiate dependence by ROC analysis","volume":"38","author":"Castillo","year":"2010","journal-title":"Actas Esp Psiquiatr"},{"issue":"7","key":"10.1016\/j.sapharm.2023.11.002_bib15","first-page":"839","article-title":"Choosing a cut-off on the severity of dependence scale (SDS) for amphetamine users","volume":"92","author":"Topp","year":"1997","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.sapharm.2023.11.002_bib16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1360-0443.2000.95224511.x","article-title":"The Severity of Dependence Scale (SDS) as screening test for benzodiazepine dependence: SDS validation study","volume":"95","author":"de las Cuevas","year":"2000","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.sapharm.2023.11.002_bib17","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.drugalcdep.2005.10.014","article-title":"The Severity of Dependence Scale (SDS) in an adolescent population of cannabis users: reliability, validity and diagnostic cut-off","volume":"83","author":"Martin","year":"2006","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"10.1016\/j.sapharm.2023.11.002_bib18","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.addbeh.2006.09.005","article-title":"Determining a cut-off on the severity of dependence scale (SDS) for alcohol dependence","volume":"32","author":"Lawrinson","year":"2007","journal-title":"Addict Behav"},{"issue":"7","key":"10.1016\/j.sapharm.2023.11.002_bib19","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/jnnp.2008.168864","article-title":"The Severity of Dependence Scale detects people with medication overuse: the Akershus study of chronic headache","volume":"80","author":"Grande","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.sapharm.2023.11.002_bib20","unstructured":"Muth\u00e9n LK, Muth\u00e9n BO. Los Angeles, CA: Muth\u00e9n & Muth\u00e9n.; 2017.."},{"key":"10.1016\/j.sapharm.2023.11.002_bib21","unstructured":"StataCorp. Stata Statistical Software: Release 9. College Station, TX: StataCorp LP.; 2005."},{"key":"10.1016\/j.sapharm.2023.11.002_bib22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1745-3992.2007.00099.x","article-title":"Introduction to structural equation modeling: issues and practical considerations","volume":"26","author":"Lei","year":"2007","journal-title":"Educ Meas"},{"issue":"2","key":"10.1016\/j.sapharm.2023.11.002_bib23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/dar.12568","article-title":"Attitudes in Australia on the upscheduling of over-the-counter codeine to a prescription-only medication","volume":"37","author":"McCoy","year":"2018","journal-title":"Drug Alcohol Rev"},{"issue":"1","key":"10.1016\/j.sapharm.2023.11.002_bib38","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11060-013-1088-4","article-title":"Screening for major depressive disorder in adults with glioma using the PHQ-9: a comparison of patient versus proxy reports","volume":"113","author":"Rooney","year":"2013","journal-title":"J Neuro Oncol"},{"key":"10.1016\/j.sapharm.2023.11.002_bib58","series-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5)","year":"2013"},{"issue":"3","key":"10.1016\/j.sapharm.2023.11.002_bib24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.drugalcdep.2004.02.004","article-title":"The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002","volume":"74","author":"Grant","year":"2004","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.sapharm.2023.11.002_bib25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0376-8716(95)01134-K","article-title":"The Alcohol Use Disorder and Associated Disabilities Interview schedule (AUDADIS): reliability of alcohol and drug modules in a general population sample","volume":"39","author":"Grant","year":"1995","journal-title":"Drug Alcohol Depend"},{"issue":"2-3","key":"10.1016\/j.sapharm.2023.11.002_bib26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0376-8716(97)01332-X","article-title":"The alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability of alcohol and drug modules in a clinical sample","volume":"44","author":"Hasin","year":"1997","journal-title":"Drug Alcohol Depend"},{"issue":"1-3","key":"10.1016\/j.sapharm.2023.11.002_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.drugalcdep.2007.06.001","article-title":"The alcohol use disorder and associated disabilities interview schedule-IV (AUDADIS-IV): reliability of new psychiatric diagnostic modules and risk factors in a general population sample","volume":"92","author":"Ruan","year":"2008","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"10.1016\/j.sapharm.2023.11.002_bib28","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/pds.3945","article-title":"A synthesis of oral morphine equivalents (OME) for opioid utilisation studies","volume":"25","author":"Nielsen","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"10.1016\/j.sapharm.2023.11.002_bib29","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s11606-009-0981-1","article-title":"Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference","volume":"24","author":"Krebs","year":"2009","journal-title":"J Gen Intern Med"},{"issue":"3","key":"10.1016\/j.sapharm.2023.11.002_bib51","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/add.14798","article-title":"Codeine use and harms in Australia: evaluating the effects of re\u2010scheduling","volume":"115","author":"Cairns","year":"2020","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.sapharm.2023.11.002_bib30","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/AJP.0b013e318208c8a2","article-title":"Measuring pain self-efficacy","volume":"27","author":"Miles","year":"2011","journal-title":"Clin J Pain"},{"issue":"8","key":"10.1016\/j.sapharm.2023.11.002_bib31","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1111\/pme.12446","article-title":"Validation of the Japanese version of the pain self-efficacy questionnaire in Japanese patients with chronic pain","volume":"15","author":"Adachi","year":"2014","journal-title":"Pain Med"},{"issue":"8","key":"10.1016\/j.sapharm.2023.11.002_bib32","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/papr.12242","article-title":"The pain self-efficacy questionnaire: cross-cultural adaptation into Italian and assessment of its measurement properties","volume":"15","author":"Chiarotto","year":"2015","journal-title":"Pain Pract"},{"issue":"1","key":"10.1016\/j.sapharm.2023.11.002_bib33","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/scs.12232","article-title":"The adaptation of a Danish version of the Pain Self-Efficacy Questionnaire: reliability and construct validity in a population of patients with fibromyalgia in Denmark","volume":"30","author":"Rasmussen","year":"2016","journal-title":"Scand J Caring Sci"},{"issue":"1","key":"10.1016\/j.sapharm.2023.11.002_bib34","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1027\/1015-5759\/a000092","article-title":"Psychometric properties of the Pain Self-Efficacy Questionnaire (PSEQ): validation, prediction, and discrimination quality of the Dutch version","volume":"28","author":"van der Maas","year":"2012","journal-title":"Eur J Psychol Assess"},{"issue":"9","key":"10.1016\/j.sapharm.2023.11.002_bib35","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"issue":"12","key":"10.1016\/j.sapharm.2023.11.002_bib36","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/00005650-200412000-00006","article-title":"Monitoring depression treatment outcomes with the patient health questionnaire-9","volume":"42","author":"L\u00f6we","year":"2004","journal-title":"Med Care"},{"issue":"2","key":"10.1016\/j.sapharm.2023.11.002_bib37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1037\/1040-3590.19.2.247","article-title":"The PHQ-9 as a brief assessment of lifetime major depression","volume":"19","author":"Cannon","year":"2007","journal-title":"Psychol Assess"},{"issue":"8","key":"10.1016\/j.sapharm.2023.11.002_bib39","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1590\/S0102-311X2013001200006","article-title":"[Sensitivity and specificity of the Patient Health Questionnaire-9 (PHQ-9) among adults from the general population]","volume":"29","author":"Santos","year":"2013","journal-title":"Cad Sa\u00fade P\u00fablica"},{"issue":"10","key":"10.1016\/j.sapharm.2023.11.002_bib40","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.sapharm.2023.11.002_bib41","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/MLR.0b013e318160d093","article-title":"Validation and standardization of the generalized anxiety disorder screener (GAD-7) in the general population","volume":"46","author":"L\u00f6we","year":"2008","journal-title":"Med Care"},{"issue":"3","key":"10.1016\/j.sapharm.2023.11.002_bib42","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jad.2010.07.010","article-title":"Validity of the GAD-7 scale as an outcome measure of disability in patients with generalized anxiety disorders in primary care","volume":"128","author":"Ruiz","year":"2011","journal-title":"J Affect Disord"},{"key":"10.1016\/j.sapharm.2023.11.002_bib43","series-title":"IBM. IBM SPSS Statistics for Windows","year":"2020"},{"key":"10.1016\/j.sapharm.2023.11.002_bib44","unstructured":"StataCorp. Stata Statistical Software: Release 17. College Station, TX: StataCorp LLC; 2021."},{"issue":"2","key":"10.1016\/j.sapharm.2023.11.002_bib45","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1093\/pm\/pnz213","article-title":"Development of a brief patient-administered screening tool for prescription opioid dependence for primary care settings","volume":"21","author":"Nielsen","year":"2020","journal-title":"Pain Med"},{"issue":"3","key":"10.1016\/j.sapharm.2023.11.002_bib46","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/add.15683","article-title":"A prospective cohort study evaluating the impact of upscheduling codeine in Australia among frequent users of codeine","volume":"117","author":"McCoy","year":"2022","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.sapharm.2023.11.002_bib47","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0376-8716(97)00088-4","article-title":"Reliability of the alcohol and drug modules of the alcohol use disorder and associated disabilities interview schedule--alcohol\/drug-revised (AUDADIS-ADR): an international comparison","volume":"47","author":"Chatterji","year":"1997","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.sapharm.2023.11.002_bib48","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0376-8716(97)00090-2","article-title":"Concordance of DSM-IV alcohol and drug use disorder criteria and diagnoses as measured by AUDADIS-ADR, CIDI and SCAN","volume":"47","author":"Cottler","year":"1997","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.sapharm.2023.11.002_bib49","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0376-8716(97)00091-4","article-title":"Concordance between ICD-10 alcohol and drug use disorder criteria and diagnoses as measured by the AUDADIS-ADR, CIDI and SCAN: results of a cross-national study","volume":"47","author":"Pull","year":"1997","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.sapharm.2023.11.002_bib50","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00004714-199908000-00014","article-title":"Characteristics of dependent and nondependent regular users of codeine","volume":"19","author":"Sproule","year":"1999","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"10.1016\/j.sapharm.2023.11.002_bib52","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1017\/ipm.2015.60","article-title":"\u2018Codeine is my companion\u2019: misuse and dependence on codeine containing medicines in Ireland","volume":"35","author":"Van Hout","year":"2018","journal-title":"Ir J Psychol Med"},{"issue":"1","key":"10.1016\/j.sapharm.2023.11.002_bib53","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13011-018-0149-2","article-title":"A comparative analysis of pharmacists' perspectives on codeine use and misuse - a three country survey","volume":"13","author":"Carney","year":"2018","journal-title":"Subst Abuse Treat Prev Pol"},{"issue":"4","key":"10.1016\/j.sapharm.2023.11.002_bib54","article-title":"Over-the-counter codeine: can community pharmacy staff nudge customers into its safe and appropriate use?","volume":"8","author":"Mody","year":"2020","journal-title":"Pharmacy (Basel)"},{"issue":"2","key":"10.1016\/j.sapharm.2023.11.002_bib55","article-title":"A snapshot investigation into the availability and access to codeine-containing medications amongst the Irish population","volume":"1","author":"O'Brien","year":"2021","journal-title":"Int Undergraduate J Health Sci"},{"key":"10.1016\/j.sapharm.2023.11.002_bib56","series-title":"Over-the-counter Opioids: Does Britain Have a Codeine Problem?","author":"Guirguis","year":"2023"},{"key":"10.1016\/j.sapharm.2023.11.002_bib57","author":"McMorrow","year":"2023"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741123004692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741123004692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:31:14Z","timestamp":1761557474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741123004692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1551741123004692"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2023.11.002","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a brief screening tool for over-the-counter codeine dependence","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2023.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}